JP7377795B2 - 眼科組成物 - Google Patents

眼科組成物 Download PDF

Info

Publication number
JP7377795B2
JP7377795B2 JP2020518337A JP2020518337A JP7377795B2 JP 7377795 B2 JP7377795 B2 JP 7377795B2 JP 2020518337 A JP2020518337 A JP 2020518337A JP 2020518337 A JP2020518337 A JP 2020518337A JP 7377795 B2 JP7377795 B2 JP 7377795B2
Authority
JP
Japan
Prior art keywords
component
ophthalmic composition
content
group
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020518337A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019216381A1 (ja
Inventor
紗衣子 林
庸子 小川
敬太 ▲高▼木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohto Pharmaceutical Co Ltd
Original Assignee
Rohto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharmaceutical Co Ltd filed Critical Rohto Pharmaceutical Co Ltd
Publication of JPWO2019216381A1 publication Critical patent/JPWO2019216381A1/ja
Priority to JP2023185466A priority Critical patent/JP2024010129A/ja
Application granted granted Critical
Publication of JP7377795B2 publication Critical patent/JP7377795B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2020518337A 2018-05-09 2019-05-09 眼科組成物 Active JP7377795B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023185466A JP2024010129A (ja) 2018-05-09 2023-10-30 眼科組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018090933 2018-05-09
JP2018090933 2018-05-09
PCT/JP2019/018588 WO2019216381A1 (ja) 2018-05-09 2019-05-09 眼科組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023185466A Division JP2024010129A (ja) 2018-05-09 2023-10-30 眼科組成物

Publications (2)

Publication Number Publication Date
JPWO2019216381A1 JPWO2019216381A1 (ja) 2021-05-27
JP7377795B2 true JP7377795B2 (ja) 2023-11-10

Family

ID=68467486

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020518337A Active JP7377795B2 (ja) 2018-05-09 2019-05-09 眼科組成物
JP2023185466A Pending JP2024010129A (ja) 2018-05-09 2023-10-30 眼科組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023185466A Pending JP2024010129A (ja) 2018-05-09 2023-10-30 眼科組成物

Country Status (3)

Country Link
JP (2) JP7377795B2 (zh)
TW (1) TW202003482A (zh)
WO (1) WO2019216381A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3691654A4 (en) 2017-09-25 2021-11-24 Surface Pharmaceuticals, Inc. OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF EYE SURFACE DISEASES
JP7467911B2 (ja) 2019-12-25 2024-04-16 ライオン株式会社 眼科用組成物及び外観安定化方法

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003183157A (ja) 2001-12-19 2003-07-03 Lion Corp 眼科用組成物
JP2005298364A (ja) 2004-04-07 2005-10-27 Rohto Pharmaceut Co Ltd アズレン含有水性液剤
WO2006112029A1 (ja) 2005-03-31 2006-10-26 Kobayashi Pharmaceutical Co., Ltd. 眼科用組成物
JP2012106999A (ja) 2010-10-29 2012-06-07 Lion Corp ソフトコンタクトレンズ用眼科組成物
JP2012250987A (ja) 2005-12-27 2012-12-20 Lion Corp ソフトコンタクトレンズ用組成物及び吸着抑制方法
JP2014098030A (ja) 2006-01-13 2014-05-29 Taisho Pharmaceutical Co Ltd 蒸発亢進型ドライアイの予防又は改善用水性点眼剤
WO2016190306A1 (ja) 2015-05-28 2016-12-01 ロート製薬株式会社 水性眼科組成物
WO2017094552A1 (ja) 2015-11-30 2017-06-08 ロート製薬株式会社 眼科組成物
JP2017206547A (ja) 2007-09-14 2017-11-24 ロート製薬株式会社 眼科用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4605837B2 (ja) * 1999-06-17 2011-01-05 株式会社メニコンネクト 点眼剤
JP2001158734A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及びソフトコンタクトレンズに対する吸着抑制方法
JP5984531B2 (ja) * 2012-06-27 2016-09-06 ロート製薬株式会社 水性眼科組成物

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003183157A (ja) 2001-12-19 2003-07-03 Lion Corp 眼科用組成物
JP2005298364A (ja) 2004-04-07 2005-10-27 Rohto Pharmaceut Co Ltd アズレン含有水性液剤
WO2006112029A1 (ja) 2005-03-31 2006-10-26 Kobayashi Pharmaceutical Co., Ltd. 眼科用組成物
JP2012250987A (ja) 2005-12-27 2012-12-20 Lion Corp ソフトコンタクトレンズ用組成物及び吸着抑制方法
JP2014098030A (ja) 2006-01-13 2014-05-29 Taisho Pharmaceutical Co Ltd 蒸発亢進型ドライアイの予防又は改善用水性点眼剤
JP2017206547A (ja) 2007-09-14 2017-11-24 ロート製薬株式会社 眼科用組成物
JP2012106999A (ja) 2010-10-29 2012-06-07 Lion Corp ソフトコンタクトレンズ用眼科組成物
WO2016190306A1 (ja) 2015-05-28 2016-12-01 ロート製薬株式会社 水性眼科組成物
WO2017094552A1 (ja) 2015-11-30 2017-06-08 ロート製薬株式会社 眼科組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
角膜表層保護剤 ムコロイド（Ｒ）点眼液１％ ムコロイド（Ｒ）点眼液３％，株式会社日本点眼薬研究所，2011年02月，<https://database.japic.or.jp/pdf/newPINS/00003847.pdf>

Also Published As

Publication number Publication date
WO2019216381A1 (ja) 2019-11-14
JP2024010129A (ja) 2024-01-23
JPWO2019216381A1 (ja) 2021-05-27
TW202003482A (zh) 2020-01-16

Similar Documents

Publication Publication Date Title
JP7324566B2 (ja) 水性眼科組成物
JP6315755B2 (ja) 異物感緩和点眼剤
JP2024010129A (ja) 眼科組成物
JP7417365B2 (ja) 水性眼科組成物
JP7355539B2 (ja) 眼科組成物
JP2020172532A (ja) 眼科用又は耳鼻科用水性組成物
JP7139500B2 (ja) 眼科組成物
JP7348347B2 (ja) 眼科組成物
JP2023126377A (ja) 眼科組成物
JP2023033557A (ja) 複合目症状改善用眼科組成物
JP2023093761A (ja) 異物感改善用眼科組成物
JP6607976B2 (ja) 異物感緩和点眼剤
JP7387835B2 (ja) 眼科組成物
JP7178470B1 (ja) 眼科組成物
JP2024059971A (ja) 洗眼剤組成物
WO2017183714A1 (ja) 眼科組成物
JP2024072698A (ja) アレルギー用眼科組成物
JP2023125656A (ja) 眼科組成物
JP2024007419A (ja) コンタクトレンズ用眼科組成物
JP2023112106A (ja) 水性眼科組成物
JP2023008962A (ja) 眼科組成物
JP2024072717A (ja) 眼科組成物
JP2021105065A (ja) 異物感緩和点眼剤
TW202027706A (zh) 含有親油性成分之眼科組合物
JP2017197526A (ja) 眼科組成物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220301

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230307

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230428

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230705

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20231003

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20231030

R150 Certificate of patent or registration of utility model

Ref document number: 7377795

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150